Watch or radiate after surgery for grade II meningioma
Part of Brain & nervous system, Cancer clinical trials.
This trial studies whether people with a grade II meningioma that has been completely removed by surgery should be monitored only or treated with radiation. It may help reduce the risk of the tumor coming back while balancing radiation side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a newly diagnosed meningioma that is only in one brain area (unifocal)
- Your surgery removed the tumor completely, with no visible remaining tumor on MRI after surgery
- The tumor was confirmed as WHO grade 2 (grade II) from pathology (tissue testing)
- You must start the trial paperwork within 180 days of your first surgery, and complete the needed post-surgery MRI in time
- You must be age 18 or older and be well enough to do usual daily activities (performance status 0–1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches for people who have had surgery to remove a meningioma, a usually non-cancerous brain tumor. Depending on the tumor's risk level, participants either receive radiation therapy or are observed without additional treatment, to see which approach provides better control.
This study tests whether modern radiation methods—possibly including proton therapy—can treat intracranial meningioma while better protecting thinking and memory. It will look at imaging results and changes in neurocognitive (thinking/memory) function over time.
This trial tests a radiation plan that gives treatment in fewer, larger “fractions” using proton beams (or sometimes photon beams) for certain non-cancer brain tumor types. It aims to see how well this approach works while keeping side effects manageable.
This trial studies whether radiation given after complete surgery can reduce regrowth of atypical (grade II) meningioma in certain people. It is mainly for tumors that did not involve the brain’s venous sinus and for patients who can safely have follow-up brain MRI scans.
This study tests a type of focused radiation therapy (called stereotactic radiosurgery) given after surgery for certain meningiomas. The goal is to see if this treatment helps prevent the tumor from coming back, and to check its safety.
This trial uses a special PET scan to find active tumor areas and then delivers a stronger dose of radiation to those spots. It is for people with aggressive or returning meningiomas who have not had brain radiation before.
Hear when a new Intracranial Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.